| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.22M | 111.65M | 147.22M | 162.85M | 153.58M | 128.04M |
| Gross Profit | 30.90M | 25.63M | 14.60M | 28.60M | 31.63M | 28.55M |
| EBITDA | -27.37M | -38.37M | -185.49M | -53.59M | -11.38M | -6.67M |
| Net Income | -34.84M | -42.89M | -182.60M | -74.71M | -9.38M | -16.82M |
Balance Sheet | ||||||
| Total Assets | 226.14M | 233.33M | 278.67M | 935.11M | 703.91M | 452.23M |
| Cash, Cash Equivalents and Short-Term Investments | 22.20M | 30.22M | 22.11M | 55.38M | 79.32M | 41.16M |
| Total Debt | 66.29M | 71.71M | 70.89M | 377.65M | 221.50M | 168.63M |
| Total Liabilities | 185.55M | 180.12M | 205.08M | 592.97M | 367.30M | 326.46M |
| Stockholders Equity | -66.33M | -57.65M | -55.38M | 208.84M | 218.02M | 43.27M |
Cash Flow | ||||||
| Free Cash Flow | -24.52M | -41.01M | -130.87M | -152.97M | -127.54M | -100.57M |
| Operating Cash Flow | -16.75M | -30.23M | -66.76M | -30.56M | -38.95M | 26.63M |
| Investing Cash Flow | -19.83M | 10.90M | -27.80M | -192.50M | -149.62M | -154.48M |
| Financing Cash Flow | 16.73M | 32.52M | 64.76M | 198.13M | 229.91M | 153.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $60.65B | 70.54 | 7.61% | 0.77% | 10.49% | -32.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | C$53.64M | ― | -3.01% | ― | 63.49% | -133.70% | |
53 Neutral | $22.33B | -14.20 | <0.01% | 0.14% | -10.87% | -168.62% | |
50 Neutral | C$388.80M | -10.92 | ― | ― | 28.43% | 80.34% |
The recent earnings call for Anaergia, Inc. was marked by a predominantly positive sentiment, reflecting significant improvements in key financial metrics. The company reported substantial growth in revenue, margins, and adjusted EBITDA, signaling strong operational performance and increasing customer confidence. Despite these advancements, the company still reported a net loss, which remains a concern for stakeholders.
Anaergia Inc. has reported significant financial improvements under the leadership of its new CEO, with a 77% increase in revenue and a return to positive Adjusted EBITDA in the third quarter of 2025. The company’s strategic realignment has bolstered its operational efficiency and profitability, supported by a growing revenue backlog and expanding project pipeline. Anaergia’s focus on technology innovation and sustainability positions it as a leader in the renewable natural gas and waste-to-value sectors, helping clients meet decarbonization goals while generating carbon-negative fuels. The company aims to build on its 2025 momentum by expanding service revenues and maintaining financial discipline to drive shareholder value and environmental impact.
The most recent analyst rating on (TSE:ANRG) stock is a Sell with a C$2.00 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc. reported a significant financial turnaround in the third quarter of 2025, with a 77% increase in revenue and a 146% rise in gross profit year-over-year. The company returned to positive Adjusted EBITDA, reflecting the success of its capital-light business model and strong market demand for renewable energy solutions. Anaergia’s revenue backlog grew to $287 million, indicating a robust project pipeline and a positive growth trajectory, as it continues to capitalize on its leadership in the renewable natural gas sector.
The most recent analyst rating on (TSE:ANRG) stock is a Sell with a C$2.00 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc. has scheduled a conference call for November 12, 2025, to discuss its third-quarter financial results, which will be released after market close on November 11, 2025. The call will feature key executives and will be accessible via a webcast, with a replay available for one year. This announcement highlights Anaergia’s commitment to transparency and engagement with stakeholders, potentially impacting its market perception and investor relations.
The most recent analyst rating on (TSE:ANRG) stock is a Sell with a C$2.00 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc., through its subsidiary Anaergia S.r.l., has entered a joint venture with Tozzi Sud and Isolmec Group to construct an anaerobic digestion facility for BioHold in Basilicata, Italy. This C$22 million project, named Ora Biogas, will process agricultural residues to produce renewable gas, generating over 47,000 megawatt-hours of biomethane annually for Italy’s gas network. The collaboration highlights Anaergia’s strategic partnerships and its commitment to advancing sustainable energy solutions, reinforcing its position in the renewable energy sector.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia, through its subsidiary Anaergia S.r.l, has entered into an agreement to upgrade Società Agricola Zilio’s anaerobic digestion facility in Veneto, Italy. The project will nearly double the plant’s feedstock capacity and increase renewable natural gas production to over 20,000 megawatt-hours annually, contributing to Italy’s national gas grid. This initiative exemplifies Anaergia’s capability to deliver customized solutions that enhance renewable energy output, supporting Italy’s transition to sustainable energy and generating projected revenues exceeding C$4.7 million by mid-2026.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc. has announced an agreement to provide engineering, procurement, and construction (EPC) and operations and maintenance (O&M) services for a renewable natural gas project in Riverside, California. This agreement aligns with Anaergia’s ‘capital-light’ strategy by selling its Riverside development project to a developer with institutional investor funding, reducing financial exposure while advancing the project. The project is expected to significantly decrease the carbon footprint of Riverside’s Water Quality Control Plant and comply with California’s SB1383 regulations for organic waste recycling.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc. has entered into an agreement with Bioenerys to expand and upgrade an anaerobic digestion facility in Ariano nel Polesine, Italy. This project, similar to a previous one in Moglia, Italy, will enhance the processing capacity for agricultural residues and significantly increase biomethane production. The upgrade is expected to generate approximately C$11 million in revenue for Anaergia and strengthen Bioenerys’ position as a key renewable energy provider.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc., through its subsidiary Anaergia S.r.l., has signed a contract with Nortegas Renovables to construct an anaerobic digestion facility in southern Spain. This project, which is expected to generate C$18 million in revenue, will transform agricultural residue into renewable biomethane, reinforcing Anaergia’s commitment to sustainable energy solutions and enhancing its position in the renewable natural gas industry.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc., through its subsidiary Anaergia S.r.l., has entered into a binding agreement with a Spanish company to provide infrastructure and equipment for over 15 new biomethane plants in Spain, anticipating C$184 million in revenue. This agreement, marking Anaergia’s largest capital sale, is expected to significantly enhance Spain’s renewable energy sector and underscores Anaergia’s strategic focus on leveraging proprietary technologies to expand its presence in Europe.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.